Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Eagle Capital Growth Fund (GRF)

Eagle Capital Growth Fund (GRF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 3,744 K
  • Annual Income, $ 3,552 K
  • 60-Month Beta N/A
  • Price/Sales 2.80
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade GRF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.23 +1.63%
on 08/19/21
9.57 -2.04%
on 09/16/21
+0.12 (+1.30%)
since 08/17/21
3-Month
8.60 +9.07%
on 07/30/21
9.57 -2.04%
on 09/16/21
+0.29 (+3.19%)
since 06/17/21
52-Week
6.65 +41.05%
on 09/25/20
9.57 -2.04%
on 09/16/21
+2.15 (+29.74%)
since 09/17/20

Most Recent Stories

More News
Eagle Capital Growth Fund Elects Anne M. Nichols, CFA as Director; Expands Stock Repurchase Authority

The Board of Directors of Eagle Capital Growth Fund, Inc. ("Fund") (NYSE American: GRF) at a regular Board meeting today unanimously elected Anne M. Nichols, CFA as a Director.

GRF : 9.38 (+0.11%)
Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B

, /PRNewswire/ -- a leading global producer of plasma-derived medicines and provider of a variety of postexposure prophylaxis and IgG products for patients, today began commercializing HyperHEP B, a new...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Grifols takes another step in the fight against Alzheimer's, partners with Ace to open first AMBAR® Center in Barcelona

- - , /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines with a history of more than 110 years contributing to improve the health...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Grifols and Andorran government will establish world-class immunology research hub to expand global knowledge of the immune system and develop therapeutics

, /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines with a history of more than 110 years contributing to improve the health and...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Eagle Capital Growth Fund Elects New Director Jason W. Allen, and Bids Farewell to Retiring Director Peggy L. Schmeltz

Eagle Capital Growth Fund, Inc. ("Fund") (NYSE American: GRF) announced that the Board, at its Board meeting today, elected Jason W. Allen as a Director. Jason is a partner with Foley & Lardner LLP (an...

GRF : 9.38 (+0.11%)
Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030

, /PRNewswire/ --Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived medicines with a track record of more than 100 years dedicated to enhancing people's...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Grifols 2020 Annual Report on Form 20-F filed with the SEC on April 9, 2021

, /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF), (MCE: GRF.P) and (NASDAQ: GRFS) announced that it has filed its 2020 Annual Report on Form 20-F with the United States Securities and Exchange...

GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Grifols announces topline data from NIAID Phase 3 ITAC trial (INSIGHT-013) evaluating hyperimmune globulins as a treatment for hospitalized patients with COVID-19

, /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived medicines with a track record of more than 100 years dedicated to enhancing people's...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Grifols installs first-ever DG Reader Net analyzer in North America

, /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived therapies and leader in the development of innovative diagnostic solutions, today...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)
Grifols reinforces its innovation strategy after completing the acquisition of GigaGen to boost a novel method to generate a wide range of immunoglobulins

, /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P; NASDAQ: GRFS), a global healthcare company with a proven track record of more than 100 years dedicated to improving the health and well-being of people...

GIKLY : 11.9400 (-0.83%)
GRF : 9.38 (+0.11%)
GRFS : 15.39 (+6.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

GRF Dividends

Date Value
12/03/20 $0.5500
11/21/19 $0.5600
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar